| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1085909942 |
| P356 | DOI | 10.1007/S12032-017-0988-0 |
| P698 | PubMed publication ID | 28593604 |
| P50 | author | Karim Essani | Q88262213 |
| P2093 | author name string | Blair R Szymczyna | |
| Tiantian Zhang | |||
| Yogesh R Suryawanshi | |||
| P2860 | cites work | Tanapoxvirus lacking the 15L gene inhibits melanoma cell growth in vitro by inducing interferon-λ1 release | Q40336558 |
| Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells | Q40929801 | ||
| Survival rates of patients with metastatic malignant melanoma | Q42008316 | ||
| Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin | Q42049353 | ||
| Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages | Q43215243 | ||
| Tropism of Tanapox virus infection in primary human cells | Q43222842 | ||
| High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma | Q43861059 | ||
| Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells | Q43915141 | ||
| Compact, synthetic, vaccinia virus early/late promoter for protein expression. | Q45108318 | ||
| Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy | Q45180665 | ||
| China approves world's first oncolytic virus therapy for cancer treatment | Q45419325 | ||
| Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo | Q46616174 | ||
| Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy | Q48155550 | ||
| Tanapox: A New Disease Caused by a Pox Virus | Q49779556 | ||
| Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. | Q52542678 | ||
| Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. | Q54019102 | ||
| MMP2 expression is a prognostic marker for primary melanoma patients. | Q54506436 | ||
| Increased gelatinase B/matrix metalloproteinase 9 (MMP-9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis | Q57584292 | ||
| Modulations of 92kDa gelatinase B and its inhibitors are associated with HIV-1 infection in human macrophage cultures | Q72857083 | ||
| Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression | Q73949261 | ||
| Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model | Q22001064 | ||
| Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis | Q24610450 | ||
| Improved survival with vemurafenib in melanoma with BRAF V600E mutation | Q24631953 | ||
| Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells | Q26996742 | ||
| Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction | Q27477724 | ||
| MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis | Q33744153 | ||
| Matrix metalloproteinases in human melanoma | Q34010132 | ||
| Poxviruses and immune evasion | Q34172411 | ||
| Going viral with cancer immunotherapy | Q34427647 | ||
| Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma | Q34478015 | ||
| Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice | Q35110264 | ||
| Protective roles of matrix metalloproteinases: from mouse models to human cancer | Q35189024 | ||
| Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection | Q35585299 | ||
| Matrix Metalloproteinase 9 Exerts Antiviral Activity against Respiratory Syncytial Virus | Q35748831 | ||
| Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas | Q35760031 | ||
| Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo | Q36076225 | ||
| Matrix metalloproteinases: their biological functions and clinical implications | Q36198519 | ||
| Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma | Q36298608 | ||
| 'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression | Q36617875 | ||
| The tanapoxvirus 15L protein is a virus-encoded neuregulin that promotes viral replication in human endothelial cells | Q36667899 | ||
| Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs | Q36726918 | ||
| Human tanapox in Zaire: clinical and epidemiological observations on cases confirmed by laboratory studies | Q36876148 | ||
| Tanapoxvirus lacking a neuregulin-like gene regresses human melanoma tumors in nude mice | Q38741265 | ||
| Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus. | Q40102515 | ||
| Oncolytic tanapoxvirus expressing interleukin-2 is capable of inducing the regression of human melanoma tumors in the absence of T cells | Q40137994 | ||
| P433 | issue | 7 | |
| P921 | main subject | oncolytic virus | Q1560099 |
| P304 | page(s) | 129 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | Medical Oncology | Q2152666 |
| P1476 | title | Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy | |
| P478 | volume | 34 |
Search more.